Stopping Semaglutide Before Pregnancy: Timeline and Planning Current FDA guidance recommends discontinuing GLP-1 medications at least two months (8 weeks) before attempting pregnancy
Anecdotal Reports Anecdotal reports of side effects include: Redness, soreness, and swelling at the site of injection Headaches Dizziness Nausea There have been mixed results voiced by people, with some saying that it has helped them to recover from injuries, reduced pain, improved their gut health or mood, while others have reported that it has no noticeable effect
Talk to your Acubalance doc about which liposomal formulas are best, or if IV nutrient therapy is something to consider for your case
The distribution map of SEMA in the central nervous system shows a greater presence in the septal nuclei compared to LIRA.19 In addition to reducing food intake, SEMA has proven effective in modulating food preferences,12 likely through dopaminergic activation of the ventral tegmental area and a reduction in endocannabinoid tone.19 The subsequent activation of the parabrachial nucleus and other neural circuits involved in the hedonic regulation of food intake may be specific to SEMA, potentially helping to explain its differences from LIRA.19 The mechanisms involved in the improvement of glycaemic control by LIRA 3 mg and SEMA 2.4 mg are related to their incretin and glucagonostatic effects inherent to GLP-1 receptor agonism,3 as well as to those derived from weight loss, reduction in fat mass, and their associated consequences.20 Effects on other comorbidities The SCALE programme shows that the apnoea-hypopnoea index reduces in cases of sleep apnoea syndrome when LIRA is used instead of a placebo (12.2 vs 6.1, p = 0.015).21 The contribution of weight loss to the effects of LIRA treatment in the SCALE programme varies
